Default welcome msg!

(please select your language)
en de fr es ITALIAN SITE


Rayner IOL Platform

When considering an intraocular lens, what's important to you?

Reliable refractive outcomes and a low rate of post-operative complications


Rayner's Anti-Vaulting Haptic (AVH) Technology provides

  • Excellent refractive outcomes1
  • Stable centration2
Reducing dysphotopsia by design 14
  • Rayner's Enhanced Square Edge Technology shows no general increase in glare from previous models7
  • The low refractive index (1.46) of Rayacryl®
Optimal visual quality in all lighting conditions
  • Aspheric optic technology reduces higher order aberrations when compared with spherical IOLs3,4
  • Excellent contrast sensitivity3,4 and a retained depth of field from aberration-neutral aspheric optic
Low Nd: YAG capsulotomy rates

Rayner's 360° Amon-Apple Enhanced Square Edge creates an optimum barrier to reduce epithelial cell migration including the haptic-optic junction6,15

At 12 months 0.6%
At 24 months 1.7%
  9.3 ± 5.5 months
  (range 2.6 - 22.7 months)

  Follow-up period: 5.3 – 29

Study of 3,461 patients receiving Rayner C-flex 570C IOLs over a 24 month period, Nd:YAG capsulotomy rates were extremely low6

An IOL free from vacuoles and glistenings7
  • Single piece IOLs created from Rayacryl® an homogeneous material free of microvacuoles, resulting in a glistening free IOL
  • Compressible material for delivery through a small incision
  • Excellent handling characteristics with controlled unfolding within the capsular bag
  • Low silicone oil adherence8
  • Excellent uveal biocompatibility9
  • Hydrophilic acrylic material with low inflammatory response10


1. Percival SPB et al. Eye 2002 May;16(3):309-315
2. Alberdi R et al. J Refract Surg. 2012;28(10):696-700
3. Nanavaty MA et al. J Cataract Refract Surg. 2009; 35:663-671
4. Yagci R et al. Eur J Ophthalmol. 2014 Jul 24;24(5):688-92
6. Mathew RG and Coombes AGA. Ophthalmic Surg Lasers Imaging. 2010 Nov-Dec;41(6):651-5
7. Rayner data on file
8. McLoone E et al. Br J Ophthalmol. 2001;85:54-545
9. Tomlins PJ et al. J Cataract Refract Surg. 2014; 40:618-625
10. Richter-Mueksch S et al. J Cataract Refract Surg. 2007; 33:1414-1418
14. Vyas A. Clin Exp Ophthalmol 2015, 6(1):391
15. Vyas A et al. J. Cataract Refract Surg 2007, 33:81-87